GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Cash Flow from Investing

Core Laboratories (Core Laboratories) Cash Flow from Investing : $-6.3 Mil (TTM As of Mar. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Core Laboratories Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Mar. 2023, Core Laboratories spent $2.2 Mil on purchasing property, plant, equipment. It gained $0.0 Mil from selling property, plant, and equipment. It spent $0.0 Mil on purchasing business. It gained $0.0 Mil from selling business. It spent $0.0 Mil on purchasing investments. It gained $0.0 Mil from selling investments. It received $0.1 Mil from net Intangibles purchase and sale. And it received $0.1 Mil from other investing activities. In all, Core Laboratories spent $2.0 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Mar. 2023.


Core Laboratories Cash Flow from Investing Historical Data

The historical data trend for Core Laboratories's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core Laboratories Cash Flow from Investing Chart

Core Laboratories Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -70.64 -5.68 7.85 -10.22 -3.86

Core Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 -2.79 -2.56 1.06 -2.04

Core Laboratories Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Core Laboratories's Cash Flow from Investing for the fiscal year that ended in Dec. 2022 is calculated as:

Core Laboratories's Cash Flow from Investing for the quarter that ended in Mar. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core Laboratories  (NYSE:CLB) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Core Laboratories's purchase of property, plant, equipment for the three months ended in Mar. 2023 was $-2.2 Mil. It means Core Laboratories spent $2.2 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Core Laboratories's sale of property, plant, equipment for the three months ended in Mar. 2023 was $0.0 Mil. It means Core Laboratories gained $0.0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Core Laboratories's purchase of business for the three months ended in Mar. 2023 was $0.0 Mil. It means Core Laboratories spent $0.0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Core Laboratories's sale of business for the three months ended in Mar. 2023 was $0.0 Mil. It means Core Laboratories gained $0.0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Core Laboratories's purchase of investment for the three months ended in Mar. 2023 was $0.0 Mil. It means Core Laboratories spent {stock_data.stock.currency_symbol}}0.0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Core Laboratories's sale of investment for the three months ended in Mar. 2023 was $0.0 Mil. It means Core Laboratories gained $0.0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Core Laboratories's net Intangibles purchase and sale for the three months ended in Mar. 2023 was $0.1 Mil. It means Core Laboratories received $0.1 Mil from net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Core Laboratories's cash from discontinued investing activities for the three months ended in Mar. 2023 was 0.0 Mil. It means Core Laboratories paid $0.0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Core Laboratories's cash from other investing activities for the three months ended in Mar. 2023 was $0.1 Mil. It means Core Laboratories received $0.1 Mil from other investing activities.


Core Laboratories Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Core Laboratories (Core Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
6316 Windfern Road, Houston, TX, USA, 77040
Core Laboratories is the premier provider of reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Executives
Katherine Murray director 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli officer: SVP, Gen Counsel & Secretary C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng director C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler officer: SVP C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith director P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique director P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland director DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno officer: President 6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig officer: VP, Counsel & Secretary 6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett director 853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels officer: CAO & Treasurer 6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen director 68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes director 6316 WINDFERN ROAD, HOUSTON TX 77040